PubMed · 1985 · 90 citations · 19 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyClinical CardiologyPerioperative PharmacologyAntiarrhythmic TherapyArrhythmia PharmacotherapyCardiac MedicationsCardiac PharmacotherapyMyocardial ProtectionPreoperative Medication ManagementControl Group DesignMatched Control GroupPerioperative Arrhythmia ManagementPerioperative Beta Blocker TherapyPostoperative Arrhythmia PreventionPostoperative ArrhythmiasPropranolol TherapyVentricular Arrhythmia Pharmacotherapy
After aorta-coronary bypass grafting, 164 consecutive patients were randomized to receive propranolol 5 mg every 6 hours orally (n = 82) or to serve as control subjects (n = 82). All patients were receiving beta blockers preoperatively. There were no significant differences between the two groups. The incidence of sustained supraventricular (nonsinus) tachyarrhythmias was 23% in the control group and 9.8% in the treated group (p = 0.02). The incidence of ventricular arrhythmias was 15% in the control group and 2.4% in the treated group (p = 0.005). The overall difference in clinically important arrhythmias was 38% in the control group and 12.2% in the treated group (p = 0.0002). We conclude that low-dose oral propranolol in patients who were receiving beta blockers preoperatively is effective in reducing the incidence of clinically important arrhythmias occurring after aorta-coronary bypass grafting.
19
Propranolol-Withdrawal Rebound Phenomenon
Richard R. Miller, Harold G. Olson, Ezra A. Amsterdam et al. · New England Journal of Medicine · 1975 · 408 citations
Mechanism of propranolol withdrawal phenomena.
Stanley Nattel, Robert E. Rangno, Gunther van Loon · Circulation · 1979 · 203 citations · Full text